Zepbound 2.5 MG/0.5 ML pen 0.5ML
Ended Awarded
- Contract number
- SPE2DB26FAG84
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $7,573
Award facts
- Contract value 100% obligated
- $7,572.86 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,572.86 to AmerisourceBergen Drug Corp for the supply of Zepbound 2.5 mg/0.5 mL pens on October 28, 2025, with completion scheduled for October 29, 2025. This is a firm fixed price delivery order with no set-aside designation, meaning it was competitively awarded. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a potential value of $999,999,999.00 and extends through December 2026.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the DLA's Medical Supply Chain. The company's broad federal contract portfolio demonstrates extensive experience delivering a comprehensive range of pharmaceutical products, from brand-name and generic medications to vaccines and specialized medical supplies across multiple therapeutic domains. This specific delivery order for Zepbound, a GLP-1 receptor agonist diabetes medication, reflects the company's role in supplying specialty pharmaceuticals to support Department of Defense healthcare requirements and the broader federal government.
Quick answers
Who was awarded contract SPE2DB26FAG84?
SPE2DB26FAG84 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 28, 2025.
How much is contract SPE2DB26FAG84 worth?
The government has obligated $7,573 on SPE2DB26FAG84.
Is contract SPE2DB26FAG84 an order under another contract?
Yes. SPE2DB26FAG84 is a delivery order under SPE2DB22D3009, an indefinite delivery contract.
Was contract SPE2DB26FAG84 competed?
The extent of competition for SPE2DB26FAG84 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award